If you are planning to stay at top resorts in Kodaikanal, then the balasresort is the right place for you, just located in Kodaikanal Taluk. Our estate is surrounded by a lake, lush green trees, coffee plantations, and more. Call now!
Roots Analysis has announced the addition of “Polycystic Ovary Syndrome Market, 2021-2031” report to its list of offerings. Currently, there is no cure for polycystic ovary syndrome (PCOS / PCOD), however the affiliated symptoms can be treated using a combination of different types of medications, including insulin-sensitizing agents, oral contraceptives, anti-androgens and anti-obesity drugs. The research activities, including clinical investigations in this domain are being driven by both industry and non-industry players. To order this 90+ page report, which features 70+ figures, please visit https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html Key Market Insights Currently, more than 60 drugs are marketed / under development for PCOS More than 80% of the drugs in the market are designed for symptomatic treatment of PCOS whilst a few drugs are being evaluated for curing this clinical condition. Among various types of drugs available, hormonal contraceptives and insulin sensitizing agents are used for the first line treatment. Popular hormonal contraceptives include Beyaz®, Clomid®, Diane 35® and Yasmin®. More than 40 industry and non-industry players are engaged in the development of drugs for PCOS Majority of the industry players (70%) are very large firms (having more than 500 employees). North America is the current hub, where close to 45% players are based. This is followed by Europe (28%), Asia-Pacific (9%), and Middle East and North Africa (7%). Around 700 clinical trials are currently evaluating the therapeutics effects of drugs for PCOS, worldwide It is worth mentioning that more than 50% of the trials were / are being conducted in Europe and Asia-Pacific region; however, more than 80% of the patients are enrolled in clinical trials being conducted in North America. Further, 86% of the total trials are being sponsored by non-industry players. More than 400 grants have been awarded to support research on drugs for PCOS, since 2016 An estimated USD 168.2 million in grants have been awarded to various companies / organizations working in this domain during the time period between 2016 -April 2021. Almost 60% of the total grant amount was funded by the National Institute of Child Health and Human Development. Around 60 eminent scientists (identified as key opinion leaders (KOLs)) are involved in the clinical trials of drugs for PCOS More than 30% of these KOLs are associated with the organizations based in Asia-Pacific, followed by those in Middle East and North Africa (28%), North America (22%) and Europe (17%). Majority of these KOLs are currently affiliated to schools and universities. Close to 3,800 patents have been filed / granted related to PCOS, since 2016 Around 60% of these are patent applications, while rest of the patents have been granted. Further, R&D activity related to PCOS is largely concentrated in the US, where over 50% of the total number of patents were filed. Leading industry players (in terms of the size of intellectual property portfolio) include Bristol Myers Squibb, Genentech, Merck and Zafgen. The market is anticipated to grow at a CAGR of 4%, during the period 2021-2031 Growth in this domain is anticipated to be driven by the sales of insulin-sensitizing agents that are expected to capture over 45% of the market share by 2031. Further, majority share (83%) of the market is captured by oral drugs To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market/request-sample.html Key Questions Answered What are the prevalent R&D trends related to PCOS? What are the key challenges faced by stakeholders in this area? Which are the principal therapies being developed for PCOS? Who are the leading industry and non-industry players in this field? What are the contributions of big pharma players in this field? Which are the key geographies where research on polycystic ovarian syndrome is being conducted? Which are the leading administering institute centers supporting the research in this field? How has the intellectual property landscape in this market evolved over the years? Who are the key opinion leaders / experts in this field? What are the factors that are likely to influence the evolution of this market? How is the current and future market opportunity likely to be distributed across key market segments? The USD 5 billion (by 2031) financial opportunity within the PCOS market has been analyzed across the following segments: Drug Class Insulin Sensitizing Agents Oral Contraceptives Anti-Androgens Anti-Obesity Route of Administration Oral Subcutaneous Intravenous Others Key Geographical Regions North America (US, Canada) Europe (France, Germany, Italy, Spain, UK) Asia-Pacific and Rest of the World (Australia, China, India and Japan) The research includes detailed profiles of key players (listed below), each profile features an overview of the company, its financial information (if available), drug portfolio, details on recent developments, as well as an informed future outlook. AbbVie Bayer GlaxoSmithKline Lupin Pharmaceuticals Merck Pfizer Takeda Teva Pharmaceuticals For additional details, please visit https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html or email [email protected] You may also be interested in the following titles: 1. Non-hormonal Therapies for Women’s Health Market, 2021-2030 2. Squamous Non-Small Cell Lung Cancer: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031 3. Vascular Disrupting Agents Market, 2021-2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected] Contact Details Ben Johnson +1 (415) 800 3415 [email protected] Roots Analysis Web: https://medium.com/@RootsAnalysis LinkedIn: https://medium.com/@RootsAnalysis Twitter: https://medium.com/@RootsAnalysis Medium: https://medium.com/@RootsAnalysis Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/ Quora: https://rootsanalysisinsights.quora.com/
Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings. Given the frequently reported inadequacies of conventional cancer therapies and the growing need for personalized medicine, there is a marked surge in the demand for TIL-based therapies. In addition, the clinical success in this domain is likely to draw in investments that will support ongoing and anticipated therapy development initiatives. To order this 255+ page report, which features 90+ figures and 100+ tables, please visit https://www.rootsanalysis.com/reports/til-therapies-market.html Key Market Insights Over 80 TIL-based therapies are currently under development Close to 55% of the aforementioned candidates are being evaluated in clinical stages (phase I/II and above), while more than 20% therapies are in preclinical and discovery stages. Examples of late-stage clinical candidates include CCRT+TIL, Lifileucel, LTX-315 and TILs, and IOV-2001 and LN-145. More than 80% pipeline candidates are presently being developed to target solid tumors T-cell immunotherapy developers were observed to be primarily focused on the treatment of different oncological indications. It is worth noting that 17% pipeline candidates are being developed for the treatment of both hematological and solid tumors. Partnership activity within this domain has increased at a CAGR of 45%, between 2011 and 2020 The maximum partnerships related to TIL-based therapies were inked in the period 2017-2019. Majority of partnership deals signed within this domain were R&D agreements (33%), followed by technology licensing (20%) and manufacturing (15%) agreements. Over USD 2 billion has been invested by both private and public investors, across 30 instances It is important to mention that, between 2013 and 2020, majority of the funding amount was raised through other equity financing elements (33%), venture capital rounds (30%) and secondary offerings (20%). This market is anticipated to grow at a CAGR of 60.6%, during the period 2021-2030 Growth in this domain is anticipated to be primarily driven by encouraging clinical trial results and likely approval of some advanced stage therapy candidates. Further, North America (primarily the US) and Europe are expected to capture over 90% of the market share (in terms of sales-based revenues) by 2030. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/til-therapies-market.html Key Questions Answered What are the prevalent R&D trends related to TIL-based therapies? Who are the leading industry and non-industry players engaged in the development of TIL-based therapies? What challenges are commonly faced by stakeholders engaged in this domain? Who are the key investors in this domain? Who are the key opinion leaders / experts engaged in this upcoming field of therapeutics? Which types of partnership models are commonly adopted by industry stakeholders? Which regions are key contract manufacturing hubs for TIL-based therapies? Which factors are likely to influence the evolution of this upcoming market? How is the current and future market opportunity likely to be distributed across key market segments? The USD 4.3+ billion (by 2030) financial opportunity within the TIL-based therapies market has been analyzed across the following segments: Target Indication Acute Lymphoblastic Leukemia Melanoma Others Key Players Key Geographical Regions North America Europe Asia Pacific The research includes brief profiles, featuring an overview of the company, its financial information (if available), details related to its product(s), highlighting type of therapy and current development status, technology portfolio (if available), recent developments and manufacturing capabilities. Cellular Biomedicine Group Iovnace Biotherapeutics Lytix Biopharma Phio Pharmaceuticals For additional details, please visit https://www.rootsanalysis.com/reports/til-therapies-market.html or email [email protected] You may also be interested in the following titles: 1. Global T-Cell Therapies Market (5th Edition): Industry Trends and Global Forecasts, 2021-2030 2. CAR-T Cell Therapies Market (3rd Edition): Industry Trends and Global Forecasts, 2021-2030 3. TCR-based Therapies Market: Industry Trends and Global Forecasts, 2021-2030 4. Cell and Gene Therapy CROs Market: Industry Trends and Global Forecasts (2nd Edition), 2021-2030 5. Gene Therapy Market (4th Edition): Industry Trends and Global Forecasts, 2020-2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected] Contact Details Ben Johnson +1 (415) 800 3415 [email protected] Roots Analysis Web: https://medium.com/@RootsAnalysis LinkedIn: https://medium.com/@RootsAnalysis Twitter: https://medium.com/@RootsAnalysis Medium: https://medium.com/@RootsAnalysis Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/ Quora: https://rootsanalysisinsights.quora.com/
Want to book a taxi online? Then reach out to Westsuburbtaxis, we offer airport pickups and drops, corporate accounts, parcel delivery, and standard taxi services in Melbourne. Reach out to us now!
Looking for best Maxi Taxi in Melbourne? Book 13 Maxi Service in Melbourne. We provide comfortable maxi cab to & from Melbourne. Contact to get a best service from us
Inkpulse is the best tattoo shop in Chennai , offering a wide range of tattoo designs such as tribal, abstract, geometric, traditional, minimalistic, contemporary, and more. Call us!
Cập nhật giá đầu karaoke Hanet mới nhất năm 2020, Chắc chắn bạn sẽ tìm được mức giá ưu đãi nhất thị trường. Tại đây bạn có thể mua trả góp đầu hanet.
เว็บไซต์แทงบอล เป็นความแตกต่างอย่างชัดเจนสำหรับการพนันบอลในอดีตกับปัจจุบันนี้ซึ่งแต่ก่อนกับการพนันบอลกับโต๊ะแทงบอลต่างๆซึ่งจะมีข้อกำหนดอยู่หลายสิ่งหลายอย่างร่วมกัน แล้วก็ยังเป็นผลเสียโดยตรงต่อนักเล่นการพนันบอลทุกคนโดยตรงอีกด้วยไม่ว่าจะเป็นความสิ้นเปลืองค่าใช้สอย
ufabet978 เป็นช่องทางที่ดีสำหรับนักเสี่ยงดวงทุกคนที่กำลังมองหาวิถีทางสำหรับการลงทุนให้กับตนเองกับการลองสมัครเข้ามาเป็นสมาชิกกับเว็บไซต์พนันออนไลน์ยูฟ่าเบท 978 ซึ่งเป็นวิถีทางสำหรับการวางเดิมพันกับเกมการพนันออนไลน์ทุกชนิดได้ตลอดตลอดระยะเวลา
UFABET เป็นการตอบโจทย์ในสิ่งที่จำเป็นให้กับนักการพนันทุกคนได้อย่างดีเยี่ยม สำหรับเว็บพนันออนไลน์ยูฟ่าเบท กับความมากมายหลายของเกมการพนันออนไลน์ทุกหมวดหมู่ไม่ว่าจะเป็นเกมส์การเดิมพันจำพวกกีฬาต่างๆเช่นการพนันบอลออนไลน์และกีฬาอื่นๆอีกจำนวนมากอีกด้วย